HCW Biologics’ $56 Million IPO

Orrick Herrington & Sutcliffe advised HCW Biologics on the deal while Sheppard Mullin advised the underwriters. HCW Biologics Inc. (NASDAQ:HCWB) has announced that it is launching…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here